These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11224929)

  • 1. Alcohol use can result in enhanced drug metabolism in HIV pharmacotherapy.
    Flexner CW; Cargill VA; Sinclair J; Kresina TF; Cheever L
    AIDS Patient Care STDS; 2001 Feb; 15(2):57-8. PubMed ID: 11224929
    [No Abstract]   [Full Text] [Related]  

  • 2. Interactions among drugs for HIV and opportunistic infections.
    Piscitelli SC; Gallicano KD
    N Engl J Med; 2001 Mar; 344(13):984-96. PubMed ID: 11274626
    [No Abstract]   [Full Text] [Related]  

  • 3. Protease inhibitor drug interactions.
    Rose E; Romeyn M
    BETA; 1997 Sep; ():29-38. PubMed ID: 11364696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of low-dose ritonavir in protease inhibitor combination therapy.
    Cooper CL; van Heeswijk RP; Gallicano K; Cameron DW
    Clin Infect Dis; 2003 Jun; 36(12):1585-92. PubMed ID: 12802760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methadone and antiretroviral medications, part II.
    Gourevitch MN; Friedland GH
    AIDS Clin Care; 1999 May; 11(5):37, 43, 45-6. PubMed ID: 11367102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug interactions. Interactions with TMC114 and TMC125.
    TreatmentUpdate; 2006; 18(3):8-9. PubMed ID: 17211920
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiretroviral and statin drug-drug interactions.
    Ray GM
    Cardiol Rev; 2009; 17(1):44-7. PubMed ID: 19092370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double jeopardy: the hazards of drug-drug interactions.
    Flexner C
    Res Initiat Treat Action; 1998 Dec; 4(7):3-8. PubMed ID: 11366084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saquinavir interaction with midazolam: pharmacokinetic considerations when prescribing protease inhibitors for patients with HIV disease.
    Merry C; Mulcahy F; Barry M; Gibbons S; Back D
    AIDS; 1997 Feb; 11(2):268-9. PubMed ID: 9030388
    [No Abstract]   [Full Text] [Related]  

  • 10. Nutrition and herbs. Tropical fruit juices and drug interactions.
    TreatmentUpdate; 2004; 16(4):1-2. PubMed ID: 17219671
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolic abnormalities are associated with HIV and treatment.
    Murphy MJ
    Fac Notes (New Orleans La); 1999; 11(1):6-7. PubMed ID: 11810889
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug interactions. Amprenavir with low-dose ritonavir.
    TreatmentUpdate; 2006; 18(3):9-10. PubMed ID: 17211921
    [No Abstract]   [Full Text] [Related]  

  • 13. Protease inhibitors and anticonvulsants.
    Brooks J; Daily J; Schwamm L
    AIDS Clin Care; 1997 Nov; 9(11):87, 90. PubMed ID: 11364776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV protease inhibitors: pharmacologic and metabolic distinctions.
    Sommadossi JP
    AIDS; 1999 Sep; 13 Suppl 1():S29-40. PubMed ID: 10546783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary consideration and protease inhibitors.
    Lichtenstein BS
    STEP Perspect; 1996; 8(3):11-4. PubMed ID: 11364264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone, adherence and protease inhibitors.
    Treat Rev; 1997 Aug; (No 25):2-3. PubMed ID: 11364614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of protease inhibitors and the fight with drug-resistant HIV-1 variants.
    Mitsuya H; Maeda K; Das D; Ghosh AK
    Adv Pharmacol; 2008; 56():169-97. PubMed ID: 18086412
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence and risk factors for clinically significant drug interactions with antiretroviral therapy.
    Miller CD; El-Kholi R; Faragon JJ; Lodise TP
    Pharmacotherapy; 2007 Oct; 27(10):1379-86. PubMed ID: 17896893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression & HIV: assessment and treatment.
    Elliott A
    STEP Perspect; 1997; 9(1):1-5. PubMed ID: 11364269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scientific considerations for pharmacoenhancers in antiretroviral therapy.
    Arya V; Robertson SM; Struble KA; Murray JS
    J Clin Pharmacol; 2012 Aug; 52(8):1128-33. PubMed ID: 21712496
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.